Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor

ISSN: 1874-4702 (Online)
ISSN: 1874-4672 (Print)


Volume 7, 2 Issues, 2014


Download PDF Flyer




Current Molecular Pharmacology

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Michael Kahn
University of Southern California
1450 Biggy Street
Los Angeles, NRT 4501, CA 90033
USA
Email: kahnm@med.usc.edu

View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor

Author(s): Xiaopan Chen, Congxia Zheng, Jing Qian, Steven W. Sutton, Zheng Huang, L v Jianxin, Changlu Liu and Naiming Zhou

Affiliation: College of Life Sciences, Zhejiang University, Zijingang Campus, 388 Yuhang Tang Rd., Hangzhou, 310058, China

Abstract

The CB2 cannabinoid receptor is a promising therapeutic target for the treatment of inflammatory diseases, neuropathic pain, liver diseases, cancer and cardiovascular diseases. Obtaining detailed information on the internalization and trafficking of the human CB2 receptor in response to agonist will have a significant impact on drug discovery. Visualization and quantitative detection of EGFP-tagged CB2 receptor showed that, upon WIN55,212-2 stimulation, the CB2 receptor was rapidly internalized in a dose- and time-dependent manner from the cell membrane into the cytoplasm. Pretreatment with hypertonic sucrose, MDC clathrin inhibitor, or siRNA-mediated knock-down of clathrin heavy chain led to significant inhibition of agonist-induced CB2 internalization. Using the RNA interference method, we showed that knockdown of β-arrestin2 expression significantly impaired receptor internalisation. Further investigation demonstrated that the internalized CB2 receptors were co-localized with the early endosome probe and were recycled to the cell surface after the removal of agonist, but treatment with specific cell-permeable proteasome inhibitor MG132 a inhibited the recycling of internalized CB2 receptor, suggesting that the proteasome-mediated degradation pathway may be involved in CB2 internalization. Moreover, the single residue Ser352 and residue cluster S335S336T338T340 at the C-terminal tail are shown to be essential for receptor phosphorylation and β-arrestin2 association. These data provide new insights into the mechanisms regulating agonist-mediated internalization and trafficking of the human CB2 receptor


Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 7
First Page: 1
Page Count: 1
DOI: 10.2174/1874467207666140714115824
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science